Literature DB >> 21091092

Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study.

Andrea Schmitt1, Fernando Leonardi-Essmann, Pascal F Durrenberger, Eleni Parlapani, Thomas Schneider-Axmann, Rainer Spanagel, Thomas Arzberger, Hans Kretzschmar, Mario Herrera-Marschitz, Oliver Gruber, Richard Reynolds, Peter Falkai, Peter J Gebicke-Haerter.   

Abstract

OBJECTIVES: The role of neuroinflammation in schizophrenia has been an issue for long time. There are reports supporting the hypothesis of ongoing inflammation and others denying it. This may be partly ascribed to the origin of the materials (CSF, blood, brain tissue) or to the genes selected for the respective studies. Moreover, in some locations, inflammatory genes may be up-regulated, others may be down-regulated.
METHODS: Genome-wide microarrays have been used for expression profiling in post-mortem brains of schizophrenia patients. Array data have been analyzed by gene set enrichment analysis (GSEA) and further confirmed with selected genes by real-time PCR.
RESULTS: In Brodman Area 22 of left superior temporal cortex, at least 70 genes (19%) out of 369 down-regulated genes (P < 0.05) belonged to the immune system. 23 from those 70 genes were randomly selected for real-time PCR. Six reached significance level at P < 0.05.
CONCLUSIONS: The present data support a brain-specific view of the role immune-modulatory genes may play in the left superior temporal cortex in schizophrenia, because immune functions in the patients are not disturbed. In keeping with comparable, previous studies supporting the notion that schizophrenia is a disease of the synapse, we hypothesize that dysregulation of immune-related genes modifies synaptic functions and stability in this region.

Entities:  

Mesh:

Year:  2010        PMID: 21091092     DOI: 10.3109/15622975.2010.530690

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  24 in total

1.  Gene expression in superior temporal cortex of schizophrenia patients.

Authors:  C Sellmann; L Villarín Pildaín; A Schmitt; F Leonardi-Essmann; P F Durrenberger; R Spanagel; T Arzberger; H Kretzschmar; M Zink; O Gruber; M Herrera-Marschitz; R Reynolds; P Falkai; P J Gebicke-Haerter; F Matthäus
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-11-28       Impact factor: 5.270

2.  The workflow from post-mortem human brain sampling to cell microdissection: a Brain Net Europe study.

Authors:  David Meyronet; Aline Dorey; Patrick Massoma; Catherine Rey; Eudeline Alix; Karen Silva; Corinne Perrin; Isabelle Quadrio; Armand Perret-Liaudet; Nathalie Streichenberger; Nicole Thomasset; Jérôme Honnorat; Thomas Arzberger; Hans Kretzschmar
Journal:  J Neural Transm (Vienna)       Date:  2015-05-16       Impact factor: 3.575

Review 3.  Neurobiological effects of aerobic exercise, with a focus on patients with schizophrenia.

Authors:  Isabel Maurus; Alkomiet Hasan; Astrid Röh; Shun Takahashi; Boris Rauchmann; Daniel Keeser; Berend Malchow; Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-05-21       Impact factor: 5.270

Review 4.  Systems psychopharmacology: A network approach to developing novel therapies.

Authors:  Peter J Gebicke-Haerter
Journal:  World J Psychiatry       Date:  2016-03-22

Review 5.  Clozapine as a Model for Antipsychotic Development.

Authors:  Frederick C Nucifora; Marina Mihaljevic; Brian J Lee; Akira Sawa
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

Review 6.  Glial Cell Abnormalities in Major Psychiatric Diseases: A Systematic Review of Postmortem Brain Studies.

Authors:  Shu-Han Liu; Yang Du; Lei Chen; Yong Cheng
Journal:  Mol Neurobiol       Date:  2022-01-11       Impact factor: 5.590

7.  Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study.

Authors:  Pascal F Durrenberger; Francesca S Fernando; Samira N Kashefi; Tim P Bonnert; Danielle Seilhean; Brahim Nait-Oumesmar; Andrea Schmitt; Peter J Gebicke-Haerter; Peter Falkai; Edna Grünblatt; Miklos Palkovits; Thomas Arzberger; Hans Kretzschmar; David T Dexter; Richard Reynolds
Journal:  J Neural Transm (Vienna)       Date:  2014-08-13       Impact factor: 3.575

8.  Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysis.

Authors:  Johanna Hass; Esther Walton; Carrie Wright; Andreas Beyer; Markus Scholz; Jessica Turner; Jingyu Liu; Michael N Smolka; Veit Roessner; Scott R Sponheim; Randy L Gollub; Vince D Calhoun; Stefan Ehrlich
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-01-15       Impact factor: 5.067

9.  Structural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patients.

Authors:  Andrea Schmitt; Fernando Leonardi-Essmann; Pascal F Durrenberger; Sven P Wichert; Rainer Spanagel; Thomas Arzberger; Hans Kretzschmar; Mathias Zink; Mario Herrera-Marschitz; Richard Reynolds; Moritz J Rossner; Peter Falkai; Peter J Gebicke-Haerter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-23       Impact factor: 5.270

10.  Schizophrenia: from epidemiology to rehabilitation.

Authors:  Gioia Mura; Donatella Rita Petretto; Krishna M Bhat; Mauro Giovanni Carta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2012-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.